R Bordet

Summary

Country: France

Publications

  1. ncbi request reprint Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique
    R Bordet
    Réseau de Recherche et d Expérimentation Psychopharmacologique REPP, Centre Hospitalier et Universitaire, Lille, France
    Am J Psychiatry 155:1346-51. 1998
  2. ncbi request reprint [Preventive neuroprotection: from experimental data to therapeutic strategies]
    R Bordet
    Service de Pharmacologie Hospitaliere, Faculté de Médecine et CHU, Lille, France
    Therapie 57:540-7. 2002
  3. ncbi request reprint [Drug-resistant partial epilepsy: pharmacological criteria]
    R Bordet
    EA1046 Laboratoire de Pharmacologie, Faculte de Medecine de Lille, 2 place de Verdun, 59045 Lille Cedex, France
    Rev Neurol (Paris) 160:5S36-42. 2004
  4. pmc PPARs: a new target for neuroprotection
    R Bordet
    J Neurol Neurosurg Psychiatry 77:285-7. 2006
  5. ncbi request reprint PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases
    R Bordet
    EA1046 Department of Medical Pharmacology, Faculty of Medicine, Institute of Predictive Medicine and Therapeutic Research, University Lille 2 and Lille University Hospital, 1 place de Verdun, 59045 Lille Cedex, France email
    Biochem Soc Trans 34:1341-6. 2006
  6. ncbi request reprint Neurogliovascular unit after cerebral ischemia: is the vascular wall a pharmacological target
    M Bastide
    Laboratoire de Pharmacologie, Faculte de Medecine, 1, Place de Verdun, 59045 Lille Cedex, France
    Psychoneuroendocrinology 32:S36-9. 2007
  7. doi request reprint [Revisiting pharmacological actions of antidepressants: the example of escitalopram]
    R Bordet
    Département de Pharmacologie médicale, Université Lille2 et CHU de Lille
    Encephale 34:S105-10. 2008
  8. ncbi request reprint Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity
    D Deplanque
    Department of Pharmacology, EA 1046, Institut de Médecine Prédictive et de Recherche Thérapeutique, University Hospital of Lille, France
    Neurology 67:1403-10. 2006

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique
    R Bordet
    Réseau de Recherche et d Expérimentation Psychopharmacologique REPP, Centre Hospitalier et Universitaire, Lille, France
    Am J Psychiatry 155:1346-51. 1998
    ..The purpose of this study was to investigate the effect of pindolol to accelerate the onset of action of paroxetine in patients suffering from major depression...
  2. ncbi request reprint [Preventive neuroprotection: from experimental data to therapeutic strategies]
    R Bordet
    Service de Pharmacologie Hospitaliere, Faculté de Médecine et CHU, Lille, France
    Therapie 57:540-7. 2002
    ..In future, the prevention treatment of stroke occurrence may be completed by preventive neuroprotective treatment. Moreover, some drugs could have potentially both preventive and neuroprotective properties, which are likely linked...
  3. ncbi request reprint [Drug-resistant partial epilepsy: pharmacological criteria]
    R Bordet
    EA1046 Laboratoire de Pharmacologie, Faculte de Medecine de Lille, 2 place de Verdun, 59045 Lille Cedex, France
    Rev Neurol (Paris) 160:5S36-42. 2004
    ..Such a diagnostic process identifying real drug-resistant epilepsy is necessary to progress in knowledge of the pathophysiology and in treatment strategy of this category of epilepsy...
  4. pmc PPARs: a new target for neuroprotection
    R Bordet
    J Neurol Neurosurg Psychiatry 77:285-7. 2006
  5. ncbi request reprint PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases
    R Bordet
    EA1046 Department of Medical Pharmacology, Faculty of Medicine, Institute of Predictive Medicine and Therapeutic Research, University Lille 2 and Lille University Hospital, 1 place de Verdun, 59045 Lille Cedex, France email
    Biochem Soc Trans 34:1341-6. 2006
    ..Beyond neuroprotection in cerebral ischaemia, PPARs are also pertinent pharmacological targets to induce neuroprotection in chronic neurodegenerative diseases...
  6. ncbi request reprint Neurogliovascular unit after cerebral ischemia: is the vascular wall a pharmacological target
    M Bastide
    Laboratoire de Pharmacologie, Faculte de Medecine, 1, Place de Verdun, 59045 Lille Cedex, France
    Psychoneuroendocrinology 32:S36-9. 2007
    ....
  7. doi request reprint [Revisiting pharmacological actions of antidepressants: the example of escitalopram]
    R Bordet
    Département de Pharmacologie médicale, Université Lille2 et CHU de Lille
    Encephale 34:S105-10. 2008
  8. ncbi request reprint Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity
    D Deplanque
    Department of Pharmacology, EA 1046, Institut de Médecine Prédictive et de Recherche Thérapeutique, University Hospital of Lille, France
    Neurology 67:1403-10. 2006
    ..To determine clinical and pharmacologic factors that could influence the initial severity and short-term outcome of cerebral ischemia...